FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.64), $0.11 better than the analyst estimate of ($1.75). Revenue for the quarter came in at $177.6 million versus the consensus estimate of $168.74 million.
2021 Financial... More

